Bastion Therapeutics

Bastion Therapeutics is a pre-clinical stage biotechnology company focused on developing best-in-class Treg cell therapies, which can target the root causes of inflammatory disorders and autoimmune diseases.

Bastion’s GRIT™ (Genetically Reconfigured & Improved Treg) platform technology utilises genetic engineering to restore and enhance the patient’s Treg function while also targeting Tregs to specific sites of tissue inflammation. Bastion’s vision is to provide curative treatments that can transform the lives of patients rather than simply alleviate the symptoms of inflammatory disorders and autoimmune diseases.

Founded in 2023, the company intends to address a wide range of inflammatory disorders, encompassing both neuroinflammatory and peripheral conditions, through their Treg cell therapies. Bastion’s pipeline strategy includes both autologous and allogeneic Treg cell therapies designed to restore immune balance with high precision.

Subscribe for alerts on new companies featured on Startups.Bio

Archon Biosciences
Archon Biosciences is a biotech company pioneering computationally designed 'Antibody Cages' to unlock powerful therapeutic targets beyond the reach of existing modalities. Archon directly applies generative protein design to rapidly …
Cytospire Therapeutics
Founded in 2023, Cytospire Therapeutics is developing a portfolio of next-generation immune cell engagers for treating cancer. The company's multispecific antibodies are designed to harness and direct the power of …
This Week in Biotech Venture Capital
The biotech sector continues to see a strong flow of new venture capital deals, with a flurry of new announcements this week. We saw a diverse set of companies—ranging from …
THRONCAT
THRONCAT is a new startup that aims to transform the field of protein analysis and mRNA therapeutics safety. THRONCAT began with a mission to make protein analysis more accessible and …

View all recently featured startups

Tags: